Sarbjit S. Saini

Sarbjit S. Saini

Allergy and Immunology
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

IgE Antibody Heterogeneity in Chronic Spontaneous Urticaria and Response to Omalizumab.

IgE Antibody Heterogeneity in Chronic Spontaneous Urticaria and Response to Omalizumab.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 09, 2026

Identifying and addressing problematic studies in allergy and asthma research: a commentary.

Identifying and addressing problematic studies in allergy and asthma research: a commentary.

Journal: The journal of allergy and clinical immunology. In practice
Published: May 08, 2026

Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2.

Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 13, 2026

Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Pooled Analysis of REMIX-1 and REMIX-2 Trials.

Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Pooled Analysis of REMIX-1 and REMIX-2 Trials.

Journal: The journal of allergy and clinical immunology. In practice
Published: March 02, 2026

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

Dupilumab in Patients With Chronic Spontaneous Urticaria: Phase 3 LIBERTY-CSU CUPID Randomized Clinical Trials.

Journal: JAMA dermatology
Published: February 18, 2026

Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond.

Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond.

Journal: The journal of allergy and clinical immunology. In practice
Published: October 21, 2025

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Journal: Allergy
Published: October 15, 2025

Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review.

Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review.

Journal: JAMA dermatology
Published: October 08, 2025

Emerging IgE and non-IgE targeted therapies for chronic urticaria.

Emerging IgE and non-IgE targeted therapies for chronic urticaria.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: September 22, 2025

Dupilumab in patients with cold urticaria: Results from a phase 3 trial.

Dupilumab in patients with cold urticaria: Results from a phase 3 trial.

Journal: The journal of allergy and clinical immunology. Global
Published: September 19, 2025

Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria.

Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria.

Journal: The journal of allergy and clinical immunology. Global
Published: August 11, 2025

An opportunity to improve the quality of care for patients with chronic spontaneous urticaria: A reimagined 3-step real-world study protocol.

An opportunity to improve the quality of care for patients with chronic spontaneous urticaria: A reimagined 3-step real-world study protocol.

Journal: The journal of allergy and clinical immunology. Global
Published: July 16, 2025
Showing 1-12 of 83

Last Updated: 09/26/2026